Actinium Pharmaceuticals (ATNM) stock forecast for 2022 – 2027

Are you interested in Actinium Pharmaceuticals, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ATNM stock price in 2022-2027. Is ATNM a good long term stock? When should I take profit in Actinium Pharmaceuticals stock? Buy or sell stock? Will ATNM stock price go up? What are analysts’ forecasts for ATNM stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. ATNM stock returns are also predicted based on historical data.

According to our research, ATNM stock is a awesome long-term investment. ATNM share price has been in a bull cycle for the past year. Actinium Pharmaceuticals, Inc. stock trend is positive.

Actinium Pharmaceuticals company info

Industry Biotechnology
Address 275 Madison Avenue, New York, NY, 10016, United States
Website https://www.actiniumpharma.com

Forecasting

52 Week High: 8.50925 USD
52 Week Low: 5.253 USD
1 Year Forecast: 8.2565 USD
5 Year Forecast: 21.219 USD

Agilent Technologies info

Market Cap: 119.19M
52 Week Change: -2.937%
52 Week High: 10.3 USD
52 Week Low: 4.91 USD
Beta: 0.827724
50 Day Moving Average: 6.04
90 Day Moving Average: 6.703
200 Day Moving Average: 7.02
Resistance Level: 5.88123
Pivot Point: 5.39037
Support Level: 4.97223
Enterprise Value: 57,403,588
Forward P/E: -4.12
Forward EPS: -1.27
Profit Margin: 0.00%
Shares Outstanding: 22,030,800
EBITDA: -2.48
Held Percent Institutions: 14.05%
PEG Ratio (5Y): 0
Trailing EPS: -1.22

Actinium Pharmaceuticals stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Actinium Pharmaceuticals Stock Forecast for 2022

March 2022 5.1 6.12 20%
April 2022 6.06 6.12 0.99%
May 2022 6.12 7.07 15.52%
June 2022 6.93 5.88 -15.15%
July 2022 6.12 6.06 -0.98%
August 2022 6.06 7 15.51%
September 2022 6.93 8.16 17.75%
October 2022 8.08 7.84 -2.97%
November 2022 8.16 8.16 0%
December 2022 8 8 0%

Actinium Pharmaceuticals Stock Forecast for 2023

January 2023 7.92 7.84 -1.01%
February 2023 8.16 7.92 -2.94%
March 2023 8 9.9 23.75%
April 2023 9.8 9.9 1.02%
May 2023 10 9.9 -1%
June 2023 9.8 9 -8.16%
July 2023 9.18 8.82 -3.92%
August 2023 9.09 9.9 8.91%
September 2023 10.1 10.78 6.73%
October 2023 11.22 10.78 -3.92%
November 2023 10.78 10.78 0%
December 2023 10.78 10.89 1.02%

Actinium Pharmaceuticals Stock Forecast for 2024

January 2024 11.11 12.24 10.17%
February 2024 12.24 12.12 -0.98%
March 2024 12.24 13.26 8.33%
April 2024 12.87 13.13 2.02%
May 2024 13.26 12.74 -3.92%
June 2024 12.74 13.13 3.06%
July 2024 13 13 0%
August 2024 12.87 13.86 7.69%
September 2024 14.28 14.28 0%
October 2024 13.72 15.15 10.42%
November 2024 14.7 14.7 0%
December 2024 15.3 15.3 0%

Actinium Pharmaceuticals Stock Forecast for 2025

January 2025 15.15 15 -0.99%
February 2025 15.3 14.85 -2.94%
March 2025 14.7 16 8.84%
April 2025 15.84 15.84 0%
May 2025 16 15.84 -1%
June 2025 15.84 16.16 2.02%
July 2025 15.84 15.84 0%
August 2025 15.68 17 8.42%
September 2025 17.17 17.64 2.74%
October 2025 18.36 17.64 -3.92%
November 2025 17.82 17.64 -1.01%
December 2025 18.18 17.82 -1.98%

Actinium Pharmaceuticals Stock Forecast for 2026

January 2026 18.18 17.64 -2.97%
February 2026 18.36 18 -1.96%
March 2026 17.64 18.62 5.56%
April 2026 19.38 18.81 -2.94%
May 2026 19.38 20.2 4.23%
June 2026 20 18.81 -5.95%
July 2026 19.19 18.81 -1.98%
August 2026 18.81 19.8 5.26%
September 2026 19.6 21 7.14%
October 2026 21.21 20.58 -2.97%
November 2026 21 20.58 -2%
December 2026 20.58 21.42 4.08%

Actinium Pharmaceuticals Stock Forecast for 2027

January 2027 20.79 20.79 0%